Speedier treatment and better outcomes for high volume stroke centers

May 9, 2012 in Surgery

Treatment is faster and outcomes are better at stroke centres dealing with a high volume of , finds research published online in the Journal of NeuroInterventional Surgery.

The authors base their findings on 442 patients treated with endovascular therapy—clot busting treatment provided inside the brain via a catheter without the need for surgery—at nine specialist (tertiary) stroke centres between September 2009 and July 2011.

All the patients, whose average age was 66, arrived at the centres within eight hours of the start of their symptoms. They all had a blood clot in a major brain artery, which had cut off blood supply and caused their stroke.

The researchers collected information on age and sex, and risk factors likely to affect the success of treatment, such as high blood pressure, abnormal heart rhythms (atrial fibrillation), diabetes, and high cholesterol.

They also looked at other key factors, including the size and location of the clot, the time taken before treatment was given, and how quickly blood flow was restored (reperfusion).

The data showed that the average time to the start of treatment—insertion of a catheter through the groin—after a CT scan of the brain, and injection of the clot buster drug into the affected artery, to completion of the procedure, was 95 minutes, on average.

The researchers then looked at whether the stroke centres were high volume facilities, defined as carrying out more than 50 such procedures a year.

Around half the patients (49%) were treated in under 95 minutes, with most of these (80%) treated at high volume centres; the remaining 20% were treated at low volume centres.

Looking only at patients referred from within the hospital, only 20 of the 112 patients treated at the low volume centres would have met the recommended 120 minute door to needle time, which is considered essential for boosting the chances of survival.

This compares with 40 out of 100 patients referred from within the hospital at high volume treatment centres.

Just over half (52%) of patients were transferred from another hospital. Although there was no difference in overall procedure times between them and those referred from within the same facility, they did start their treatment sooner.

A higher proportion of patients from other facilities were referred to a high volume centre, where they were more likely to be given clot-busting drugs, and to receive faster for each of the steps involved.

They were 86% more likely to survive and 82% more likely to have blood flow successfully restored in the affected artery. Delays in reperfusion are critical: for every 30 minutes of delay, the chances of survival fall by 12%, say the authors.

"Centers that currently perform higher numbers of [endovascular stroke] procedures appear to have lower times to reperfusion, and a higher proportion of patients with successful , translating into improved ," they conclude.

More information: Higher volume endovascular stroke centers have faster times to treatment, higher reperfusion rates and higher rates of good clinical outcomes, Online First, doi 10.1136/neurintsurg-2011-010245

Provided by British Medical Journal search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Sexual function in older adults with thoracolumbar-pelvic instrumentation

Surgeons investigated sexual function in 62 patients, 50 years and older, who had received extensive spinal–pelvic instrumentation for spinal deformity at the University of Virginia Health Center. Based on their results, ...

Surgery created 16 hours ago | popularity not rated yet | comments 0

Challenges encountered in surgical management of spine trauma in morbidly obese patients

Physicians at Monash University and The Alfred Hospital in Melbourne, Australia describe the logistic, medical, and societal challenges faced in treating spine trauma in morbidly obese patients. Based on a case series of ...

Surgery created 16 hours ago | popularity not rated yet | comments 0

Study looks at risk factors for rupture or bleeding of arachnoid cysts in children

Arachnoid cysts are a common type of brain lesion that is usually harmless, but with a risk of rupture or bleeding. A new study identifies risk factors for rupture or bleeding in children with "incidentally" detected arachnoid ...

Surgery created 16 hours ago | popularity not rated yet | comments 0

Study supports 'aggressive' treatment for posterior fossa hematoma in newborns

Posterior fossa subdural hematoma (PFSDH) is a serious and rare condition in newborns, generally occurring after difficult deliveries. But with appropriate treatment, there's an excellent chance of good long-term outcomes ...

Surgery created May 20, 2013 | popularity not rated yet | comments 0

More than one-third of Texas women still receive unnecessary breast biopsy surgery

Many women in Texas who are found to have an abnormality on routine mammogram or discover a lump in one of their breasts end up having an old-fashioned surgical biopsy to find out whether the breast abnormality is malignant. ...

Surgery created May 17, 2013 | popularity not rated yet | comments 0


Phthalates: Study links chemicals widely found in plastics, processed food to elevated blood pressure in children, teens

Plastic additives known as phthalates (pronounced THAL-ates) are odorless, colorless and just about everywhere: They turn up in flooring, plastic cups, beach balls, plastic wrap, intravenous tubing and—according to the ...

If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...